Latest filing published 04 Apr 2017 for Cidara Therapeutics, Inc., €91k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Kevin Forrest: trading record in brief
Kevin Forrest appears in our data through filings on Cidara Therapeutics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 23 November 2015 to 31 March 2017, the count stands at 3 filings.
On the market, this insider has only ever bought: 3 purchases, €230k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2017 to date brings 1 purchase and no sales.
A typical purchase (the median) is worth €91k.
Most recently, on 4 April 2017, the filings show an open-market purchase worth €91k in Cidara Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Kevin Forrest
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,500 shares@ US$7.7566.9% of flowCommon StockSEC:0001209191-17-024862:0Canonical exit: 29 Jun 2017 (T+90)
- 4,356 shares@ US$11.5333.1% of flowCommon StockSEC:0001209191-16-122623:0Canonical exit: 18 Aug 2016 (T+90)
- 7,087 shares@ US$14.23Common StockSEC:0001209191-15-081857:0Canonical exit: 21 Feb 2016 (T+90)
3 of 3 declarations
